𝔖 Bobbio Scriptorium
✦   LIBER   ✦

Qualitative and quantitative analysis of orthotopic bone regeneration by marrow

✍ Scribed by Joanne R. Werntz; Joseph M. Lane; Albert H. Burstein; Robert Justin; Robert Klein; Emre Tomin


Publisher
Elsevier Science
Year
1996
Tongue
English
Weight
810 KB
Volume
14
Category
Article
ISSN
0736-0266

No coin nor oath required. For personal study only.

✦ Synopsis


Abstract

A rat model of a femoral segmental defect was used to specifically test the hypothesis that autogenous marrow has the osteogenic capability to heal a bone defect. The variables analyzed included the ratio of the marrow volume to the defect, implantation of live or dead marrow, and remodeling of established nonunions by implantation of live marrow. The uniqueness of this model allows biomechanical evaluation of the new bone formed by the implant. When live marrow was implanted, woven bone formed at 3 weeks, progressing to early lamellar bone at 6 weeks, with subsequent remodeling for as long as 12 weeks in a volumetric fashion (p < 0.05). Bone marrow, when placed in a fresh femoral defect and given in sufficient amounts, produced a rate of union comparable with that of autologous bone grafts. Mature lamellar bone formed by marrow was evaluated biomechanically: the results were statistically comparable with those of cancellous bone grafts at 12 weeks. Significant bone formation occurred when marrow was percutaneously injected in femoral nonunions, although union and remodeling did not take place in this rat model. Implantation of dead marrow resulted in rare cellular infiltration and minimal bone formation in a manner comparable with that of autogenous cancellous bone grafts. These results indicate that bone marrow can lead to structurally functional bone regeneration in an orthotopic location.


πŸ“œ SIMILAR VOLUMES


Quantitative analysis of disseminated tu
✍ GΓ‘bor MΓ©hes; Thomas LΓΆrch; Peter F. Ambros πŸ“‚ Article πŸ“… 2000 πŸ› John Wiley and Sons 🌐 English βš– 141 KB πŸ‘ 2 views

Accurate quantification of disseminated tumor cells in hematological samples is of fundamental importance in clinical oncology. However, even highly standardized protocols allow only a rough estimation of the total analyzed cell number, as sample processing may have adverse effects on the number of